Role of Oral Steroids in Reducing Recurrence of Urethral Stricture After Direct Vision Internal Urethrotomy
NCT ID: NCT05069883
Last Updated: 2021-10-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
180 participants
INTERVENTIONAL
2018-01-01
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intralesional Injection of Mitomycin C Following Visual Internal Urethrotomy for Recurrent Urethral Stricture
NCT06232005
Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy?
NCT06697106
Effect of Mitomycin C on Urethral Stricture Recurrence After Internal Urethrotomy
NCT00918528
The Effectiveness of Prophylactic Antibiotics for Urethral Bulking
NCT06261736
Effect of Ureteral Stents Length and Location on Related Symptom
NCT05069376
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oral Steroid
In this group oral steroids were given after Direct vision internal urethrotomy
Steroid Drug
In this group Oral steroid medication after Direct Vision Internal Urethrotomy
No Oral Steroids
In this group no oral steroids were given after Direct vision internal urethrotomy
No steroid
In this group no Oral steroid medication (palcebo medication) after Direct Vision Internal Urethrotomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Steroid Drug
In this group Oral steroid medication after Direct Vision Internal Urethrotomy
No steroid
In this group no Oral steroid medication (palcebo medication) after Direct Vision Internal Urethrotomy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with post-TURP strictures
* Patients with neurogenic bladder
* Patients with prior history of steroid use
* Patients with extravasation during optical internal urethrotomy
20 Years
60 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Armed Forces Institute of Urology, Rawalpindi
OTHER
Services Hospital, Lahore
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. SamiUllah
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Armed Force Institute of Urology
Rawalpindi, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AF1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.